Comparison

DMH-25 European Partner

Item no. TMO-T8569-100mg
Manufacturer TargetMol
CASRN 1685280-21-0
Amount 100 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 200 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 0,9905
Smiles N(=O)(=O)C=1C(OC=2C(C1)=CC(Br)=CC2Br)C3=CC=C(Br)C=C3
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Targets
mTOR
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
489.94
Description
DMH25 is a novel covalent and potent inhibitor of mTOR and shows in vivo antitumor activity against triple-negative breast cancer cells.
Pathways
PI3K/Akt/mTOR signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close